Antihistamine Causes
Severe Breathing Problems in Children - Promethazine HCL Should Not Be
Used On Children Under Two
April 26th 2006
|
 |
|
Promethazine HCL |
|
The Food and Drug Administration (FDA) is warning parents and doctors
that medications containing promethazine hydrochloride (HCl) should not
be used to treat children under the age of two because of possible
breathing problems. The antihistamine can be found in tablets, syrups,
injectables and even suppositories.
There are reports of breathing problems and even some deaths associated
with the drug involving children under the age of two. The FDA says
that parents and caregivers should also be careful and get a doctor’s
advice about giving promethazine HCl in any form to children age two and
older.
According to an FDA press release, “the labeling on all products, brand
name and generic, has been changed to reflect these strengthened
warnings.” The FDA is especially concerned and has alerted healthcare
professionals, other caregivers, and patients that the drug is also
found in cold and or cough syrups.
The drug was approved in 1951 and has been used for hay fever, stuffy or
runny nose due to allergies. ABC News reported that the drug has also
been sold by Wyeth under the brand name Phenergan as well as in various
generic versions.
There have been 22 reports of severe breathing problems associated with
the drug in children under the age of two. The drug can also be used to
treat or prevent nausea, vomiting, or motion sickness. Labels will be
changed for all medicines containing romethazine HCl.
By Dan Wilson
Best Syndication
Books on Heart Disease
Keywords and misspellings:
coranary
micro-vascular disfunction
iscemic iskemic
ishcemic ishcemia angiograf blood presure
stroke embolism imbolism embilism embelism bloode clot |
RSS Feed to Asthma Allergy News
